Zora Kramer Brown

The Scientist Date: February 3, 1997 Photo: Hason Miccolo Johnson THE SCIENTIST® The Newspaper for the Life Sciences Professional (609)-786-7207 For Fast Service "THE SCIENTIST provides an important source of information on what's happening within the scientific community on breast cancer research and what kinds of information scientists need to make study determinations. THE SCIENTIST is very useful." Zora Kramer Brown Executive Director Breast Cancer Resource Committee Washington, D.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The Scientist

Date: February 3, 1997

Zora Kramer Brown
Executive Director Breast Cancer Resource Committee
Washington, D.C.

Brown says the idea for the group came to her while she attended a National Cancer Institute forum in early 1989. She recalls, "Speaker after speaker talked about the high incidence of mortality among African American women but then discussed the progress being made against breast cancer among white women."

Just seven years later, Brown believes she is seeing the impact of her group's education and advocacy efforts: "We started a new session of our support group with 29 newly diagnosed women, a third of whom are in their early 30s with cancers that had been diagnosed early. That's a very positive sign."

As her group tries to encourage the scientific community to study breast cancer among African American women, Brown says, "THE SCIENTIST provides an important source of information on what's happening ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies